LifeVantage Corporation Aktie News

SALT LAKE CITY, Oct. 21, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2025, after the stock market closes on Tuesday, November 4, 2025. The Company will hold a c...

SALT LAKE CITY, Oct. 13, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer will participate in the LD Micro Main Event XIX, to be held October 19-21, 2025 in San Diego, CA.

SALT LAKE CITY, Oct. 02, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the closing of its previously announced acquisition of LoveBiome, a pioneering direct sales company dedicated to comprehensive microbiome care and wellness solutions. Under...

SALT LAKE CITY, Sept. 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the Lytham Partners Fall 2025 Investor Conference, to b...

LifeVantage reported disappointing Q4/FY2025 results as domestic sales of the company's much-touted MindBody GLP-1 System came in below expectations. Following an impressive start, MindBody GLP-1 System sales have largely failed to ride the coattails of blockbuster weight-loss drugs like Wegovy and Zepbound. The company also issued FY2026 guidance below consensus expectations. At the mid-point ...

LifeVantage Corporation (NASDAQ:LFVN ) Q4 2025 Earnings Call September 4, 2025 4:30 PM EDT Company Participants Steven Fife - President, CEO & Director Carl Aure - Chief Financial Officer Conference Call Participants Reed Anderson - ICR Inc. Douglas Lane - Water Tower Research LLC Presentation Operator Good day, ladies and gentlemen. Thank you for standing by.

SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2025.

Strategic acquisition expands network of Consultants, and strengthens LifeVantage's Activation differentiation in the rapidly growing gut health market Strategic acquisition expands network of Consultants, and strengthens LifeVantage's Activation differentiation in the rapidly growing gut health market